Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03488849 · ClinicalTrials.gov registry record

SureCRIC Standardized Patient Study

A clinical trial of Airway Obstruction, sponsored by InnoVital Systems.

Completed
Registry status
18
Enrollment target
1
Study location

NCT03488849: Completed study of Airway Obstruction, sponsored by InnoVital Systems.

NCT03488849 is a study of Airway Obstruction that has completed, run by InnoVital Systems. The registered enrollment target is 18 participants, below the 79-participant average among 4 other Airway Obstruction trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03488849, a study of Airway Obstruction, has completed, sponsored by InnoVital Systems.

COMPLETED
Registry status
18 participants
Enrollment target
1
Study location

Study Summary

SureCRIC is intended to be used as an accessory to cricothyrotomy and tracheotomy devices, helping to identify and stabilize anatomical landmarks for establishing an airway. Cricothyroid membrane identification accuracy has been reported to be 30-62% in the literature \[Bai15, Ell10, Kri15, Lam15\]. The current study assesses SureCRIC-assisted medic performance in identifying the cricothyroid membrane in a diverse standardized patient population.

Primary Outcome

pass/fail assessment for CTM identification as gauged by expert (senior orolaryngologist)

Conditions Studied

Interventions

  • DEVICE SureCRIC
  • OTHER Freehand

Study Locations (1)

District of Columbia

  • National Center for Human Factors in Healthcare - Washington D.C.

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2017-10-16
Est. Completion 2017-10-27
InnoVital Systems

1 total trials

What the finished NCT03488849 record still lists

NCT03488849 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 79-participant average among 4 other Airway Obstruction trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Airway Obstruction appearing as the primary indexed condition, and to 2 interventions - of which SureCRIC is the first listed.

NCT03488849 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT03488849 about?

NCT03488849 is a clinical study titled "SureCRIC Standardized Patient Study". SureCRIC is intended to be used as an accessory to cricothyrotomy and tracheotomy devices, helping to identify and stabilize anatomical landmarks for establishing an airway. Cricothyroid membrane identification accuracy has been reported to be 30-62% in the literature \[Bai15, Ell10, Kri15, Lam15\]...

What is the current status of trial NCT03488849?

This trial is currently completed. The enrollment target is 18 participants. The study started on 2017-10-16. Estimated completion is 2017-10-27.

What conditions does trial NCT03488849 study?

This clinical trial studies the following conditions: Airway Obstruction.

What interventions are being tested in trial NCT03488849?

The interventions under investigation include: SureCRIC (DEVICE), Freehand (OTHER).

Who is sponsoring clinical trial NCT03488849?

This trial is sponsored by InnoVital Systems, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03488849 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Airway Obstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03488849, the US trial registry maintained by the National Library of Medicine. NCT03488849 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.